课题基金 / 基金详情

IN VIVO PET IMAGING OF VOLATILE ANESTHETIC ACTION 5HT2A RECEPTOR IN HUMAN BRAIN

IN VIVO PET IMAGING OF VOLATILE ANESTHETIC ACTION 5HT2A RECEPTOR IN HUMAN BRAIN
人脑中挥发性麻醉作用 5HT2A 受体的体内 PET 成像
批准号:
6219234
负责人:
LEONARD FIRESTONE
金额:
$0.3万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

LEONARD FIRESTONE的其他基金

相关文献

中文摘要
翻译
挥发性全身麻醉剂的作用机制尚不清楚。挥发性全身麻醉剂的一个假定靶点是脑血清素受体。本研究将验证5HT2A受体在麻醉后不会显示构象变化的假设。放射性示踪剂18F-altan-serin在异氟醚麻醉浓度下的结合将通过PET测量,与不含异氟醚麻醉浓度下的结合进行比较。
英文摘要
The mechanisms of volatile general anesthetics remain unclear. One of the putative targets for volatile general anesthetics is the brain serotonin receptor. This study will test the hypothesis that the 5HT2A receptor will not show a conformational change from anesthesia. The binding of the radiotracer 18F-altan-serin will be measured by PET in the presence of an anesthetizing concentration of isoflurane to that in isoflurane's absence will be compared.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DO VOLATILE ANESTHETICS MODULATE BENZODIAZEPINE BINDING TO CEREBRAL NEURONS
DO VOLATILE ANESTHETICS MODULATE BENZODIAZEPINE BINDING TO CEREBRAL NEURONS
IN VIVO PET IMAGING OF VOLATILE ANESTHETIC ACTION 5HT2A RECEPTOR IN HUMAN BRAIN
IN VIVO IMAGING OF VOLATILE ANESTHETIC ACTION 5HT2A RECEPTOR IN HUMAN BRAIN